Aldeyra Therapeutics, Inc. (ALDX) › Net IncomeAldeyra Therapeutics, Inc. (ALDX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2013: $13.06M2014: -$5.19M2015: -$12.09M2016: -$18.70M2017: -$22.34M2018: -$38.89M2019: -$60.83M2020: -$37.55M2021: -$57.78M2022: -$62.02M2023: -$37.54M2024: -$55.85M2025: -$33.85M-$33.85M2013Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$33.85M+39.4%2024-$55.85M-48.8%2023-$37.54M+39.5%2022-$62.02M-7.4%2021-$57.78M-53.8%2020-$37.55M+38.3%2019-$60.83M-56.4%2018-$38.89M-74.1%2017-$22.34M-19.5%2016-$18.70M-54.7%2015-$12.09M-133.1%2014-$5.19M-139.7%2013$13.06M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share